Kangstem Biotech Co., Ltd. (KOSDAQ: A217730)
Health Care · Biotechnology · KR
₩2,330.00
-19.52% today · +73.4% 1Y
Kangstem Biotech Co., Ltd. (KOSDAQ: A217730) operates in the Biotechnology industry within the Health Care sector. The company is valued at $158.13M.
Over the last twelve months the share price has gained 73.4%, trading between 1.08K and 4.69K.
Tweenvest scores Kangstem Biotech Co., Ltd. across four factors: quality 31/100, value 69/100, growth 0/100. Its strongest factor is value.
A217730 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $158.13M
- Revenue (TTM)
- $1.96M
- P/E
- —
- EPS
- -130.92
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- ₩4,690.00
- 52-week low
- ₩1,080.00
- Avg volume (3M)
- —
- Shares outstanding
- 94.05M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.18 | -0.13% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $444.98 | +0.26% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.96 | +0.15% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $549.00 | +0.26% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $834.94 | +0.78% |
| argenx SEENXTBR: ARGX | $63.06B | €872.80 | +1.00% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $141.09 | +1.58% |
Figures last refreshed Aug 18, 2026.